Profil
Karen Boodram is currently the Director & Director-Corporate Strategy at Incisive Genetics, Inc. She previously worked as the Chairman at Transferra Nanosciences, Inc. and as an Independent Director at Verisante Technology, Inc. from 2009 to 2018.
She also worked as the Director-External Affairs at Novartis Pharmaceuticals Canada, Inc. and as the VP-Business Development & Investor Relations at SemBioSys Genetics, Inc. from 2010 to 2012.
Additionally, she worked as an Analyst at PI Financial Corp.
and as a Member at Alberta College of Pharmacists.
Ms. Boodram received her undergraduate degree from the University of Alberta in 1981 and her MBA from Athabasca University in 1999.
Aktive Positionen von Karen Boodram
| Unternehmen | Position | Beginn |
|---|---|---|
Incisive Genetics, Inc.
Incisive Genetics, Inc. BiotechnologyHealth Technology Manufactures genetic medicines | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Karen Boodram
| Unternehmen | Position | Ende |
|---|---|---|
| VERISANTE TECHNOLOGY INC. | Direktor/Vorstandsmitglied | 01.04.2018 |
Ventum Financial Corp.
Ventum Financial Corp. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31.12.2009 |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Alberta College of Pharmacists
Alberta College of Pharmacists Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical association | Corporate Officer/Principal | - |
Transferra Nanosciences, Inc.
Transferra Nanosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Vorsitzender | - |
Ausbildung von Karen Boodram
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
SemBioSys Genetics, Inc.
SemBioSys Genetics, Inc. BiotechnologyHealth Technology Develops protein-based pharmaceuticals and non-pharmaceutical products | Health Technology |
Verisante Technology, Inc.
Verisante Technology, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of skin cancer detection systems | Health Technology |
Ventum Financial Corp.
Ventum Financial Corp. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Athabasca University
Athabasca University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alberta College of Pharmacists
Alberta College of Pharmacists Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical association | Commercial Services |
Transferra Nanosciences, Inc.
Transferra Nanosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Incisive Genetics, Inc.
Incisive Genetics, Inc. BiotechnologyHealth Technology Manufactures genetic medicines | Health Technology |
















